Psychiatric Disorders

AASM: Position Statement on Home Sleep Apnea Testing

By October 16, 2017

HSATs are ordered by healthcare providers to help diagnosis obstructive sleep apnea (OSA) in adults.

Medication Review Reveals Patient Was on Wrong Drug for 10 Years

By October 13, 2017

The case involved a 69-year old patient with paranoid schizophrenia who was brought to the emergency department following violent behavior against the staff at the nursing facility he resided in.

Daily Dose Thresholds: Sedatives-Hypnotics

October 13, 2017

Sedative-hypnotic medications daily dose threshold chart, especially for long term care patients.

Daily Dose Thresholds: Anxiolytics

October 12, 2017

Anxiolytic medications daily dose threshold chart, especially for long term care patients.

Licensure Concerns May Be a Barrier to Clinicians Seeking Mental Health Tx

By October 11, 2017

The survey revealed that almost 40% of physicians would be reluctant to seek formal medical care for treatment of a mental health condition due to perceived repercussions to their medical licensure.

Perfect Timing: Nobel Winners Highlight Significance of Circadian Rhythms

October 04, 2017

Understanding the powerful regulation of biology by circadian rhythms is beginning to lead to far-reaching changes in policy.

Nationwide Availability of Cotempla XR-ODT for ADHD Announced

By October 02, 2017

Cotempla XR-ODT is a Schedule II controlled substance and is supplied as 8.6mg, 17.3mg, and 25.9mg strength orally-disintegrating tablets in cartons containing 5 blister cards of 6 tablets each.

Older Patients Often Use Rx and OTC Meds to Help with Sleep

By September 27, 2017

Overall among each medication type (prescription, over-the-counter and herbal/natural aids) 36% reported using some type of medication to aid their sleep.

Antidepressant Overdose Risk Should Be Considered When Choosing Depression Tx

By September 26, 2017

Results showed that bupropion users were more likely to have a seizure, have accompanied tachycardia on presentation, and be admitted to the hospital, compared to those who ingested a TCA.

FDA Rejects Vraylar sNDA for Negative Symptoms of Schizophrenia

By September 25, 2017

In the letter the FDA stated that their preliminary appraisal found that the sNDA was not sufficiently complete to permit a substantive review.

Increased Med Use Over Time Seen in Older Patients of All BMI Classes

By September 22, 2017

Researchers aimed to determine whether the rise in prescription drug use over time varied by age and obesity status.

Asthma Drug Linked to Neuropsychiatric Adverse Events

By September 21, 2017

Results found that overall depression was the most commonly reported adverse event in the VigiBase group while headaches were the most frequent adverse event reported for the Dutch database.

Sleep Deprivation: An Effective Antidepressant?

By September 21, 2017

Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed 66 studies to determine the antidepressant effects of sleep deprivation.

Intranasal Ketamine Evaluated in Fear of Harm Bipolar Phenotype

By September 20, 2017

Findings showed that almost all patients were 'much' to 'very much' improved clinically and in ratings of social function and academic performance.

Depression Found to Be Independently Associated with Recurrent Chest Pain

By September 20, 2017

On multivariable regression models, depression was a significant independent predictor of 30-day chest pain recurrence after adjustment.

ADHD Treatments

September 20, 2017

Attention Deficit Hyperactivity Disorder (ADHD) treatment medications comparative chart.

Impact of CPAP Telemonitoring with Feedback on Adherence

September 19, 2017

"The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in OSA patients," the authors wrote.

Lithium May Be Underused as Antisuicidal Agent, Review Finds

By September 19, 2017

Despite the abundance of evidence published in the past 40 years supporting lithium as an antisuicidal agent, its use is "underrepresented" and should be incorporated into clinical guidelines and practice more assertively.

Adzenys ER Approved for the Treatment of ADHD

By September 18, 2017

Adzenys ER is a once-daily extended-release liquid that does not need to be reconstituted or refrigerated.

Suicide Attempts Up; Particularly Evident Among Young Women

September 14, 2017

The researchers observed an increase in the weighted percentage of U.S. adults making a recent suicide attempt from 0.62% in 2004 to 2005 to 0.79% in 2012 to 2013 (risk difference adjusted for age, sex, and race/ethnicity [ARD], 0.17%).

Do Pets in the Bedroom Impact Sleep Quality?

By September 12, 2017

When data was stratified for dogs who slept their pet-owner's bed and dogs who just slept in the room human sleep efficiency decreased to 80.1%±7.2%, while efficiency for the dog increased from 83.3%±19.8% to 85.4%±12.1% (P=0.003).

Over 1 Million ADHD Patches Recalled Due to Liner Defect

By September 12, 2017

This error can make it difficult for patients and caregivers to remove the liners from the Daytrana patches.

Cotempla XR-ODT Available for Pediatric ADHD

By September 08, 2017

Cotempla XR-ODT contains methylphenidate, a central nervous system (CNS) stimulant.

Oral Tx for Acute Suicidal Ideation and Behavior Gets Fast Track Status

By September 06, 2017

Results from two previously Phase 2 trials of NeuroRx's sequential treatment have shown a 50% reduction in symptoms of depression and a 75% reduction in suicidal ideation in bipolar patients.

Pharmacotherapy, CBT Evaluated for Childhood Anxiety Disorders

September 05, 2017

CBT significantly improves primary anxiety symptoms compared with wait-listing/no treatment

Stress, Sleep, Obesity Connection Explored in New Study

September 05, 2017

Stress linked to impaired sleep, increased emotional rewarding of palatable foods, leading to obesity

Drug-Dietary Supplement Interaction Leads to Surgical Emergency

By September 05, 2017

This case demonstrates how important it is for clinicians to be able to identify dietary supplements that can lead to dangerous drug-drug interactions.

FDA Greenlights MDMA Studies for Posttraumatic Stress Disorder

By August 31, 2017

"Our Phase 2 data was extremely promising with a large effect size, and we are ready to move forward quickly," said Amy Emerson, Executive Director of the MAPS Public Benefit Corporation.

FDA to Review Novel ADHD Treatment Dasotraline

By August 31, 2017

Two year-long studies assessing safety of dasotraline in children, adolescent and adult ADHD patients found the treatment to be generally well tolerated.

Recall: Antipsychotic Tablets Found in Antidepressant Bottle

By August 29, 2017

A Health Hazard Evaluation indicated a high risk to the patient ingesting the foreign tablet.